Law360, New York (September 2, 2009, 5:13 PM EDT) -- Pfizer Inc. will pay $2.3 billion and one of its subsidiaries will plead guilty to a criminal charge to settle claims that the drug giant improperly marketed the discontinued anti-inflammatory drug Bextra and three other medicines, federal regulators announced Wednesday, marking the largest such settlement on record.
Pfizer first reported that it had reached the settlement in principle in a January filing with the U.S. Securities and Exchange Commission.
One unit of Pfizer, Pharmacia & Upjohn Company Inc., agreed to plead guilty to one criminal count...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.